Detalhe da pesquisa
1.
Deep sequencing of the TP53 gene reveals a potential risk allele for non-small cell lung cancer and supports the negative prognostic value of TP53 variants.
Tumour Biol
; 39(2): 1010428317694327, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28240049
2.
The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein.
BMC Cancer
; 14: 594, 2014 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25128202
3.
Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
BMC Immunol
; 11: 19, 2010 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20385003
4.
A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.
Oncologist
; 15(7): 699-731, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20584808
5.
Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer.
BMC Cancer
; 10: 117, 2010 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20346145
6.
Biomarker recommendation for PD-1/PD-L1 immunotherapy development in pediatric cancer based on digital image analysis of PD-L1 and immune cells.
J Pathol Clin Res
; 6(2): 124-137, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31922656
7.
In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53.
Mol Oncol
; 13(5): 1196-1213, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30859681
8.
Detection of microsatellite instability in colorectal cancer using an alternative multiplex assay of quasi-monomorphic mononucleotide markers.
J Mol Diagn
; 10(2): 154-9, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18258928
9.
Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.
Mol Oncol
; 12(6): 830-854, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603584
10.
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.
Cancers (Basel)
; 10(4)2018 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29690507
11.
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation.
Oncoimmunology
; 7(7): e1440167, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29900042
12.
Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients.
Clin Colorectal Cancer
; 17(2): e369-e379, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29605591
13.
A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
J Mol Diagn
; 19(1): 162-168, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27865784
14.
MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients.
J Cancer
; 8(12): 2154-2162, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28819417
15.
Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines.
Cancer Biother Radiopharm
; 32(7): 229-238, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28910149
16.
Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.
Oncotarget
; 8(43): 74058-74067, 2017 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29088768
17.
Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia.
J Cancer
; 8(8): 1441-1452, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28638459
18.
TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value.
Crit Rev Oncol Hematol
; 99: 63-73, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689115
19.
Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer.
World J Clin Oncol
; 7(6): 425-432, 2016 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28008383
20.
APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines.
Cancer Lett
; 375(2): 313-322, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26975633